Quantcast

Latest Immunoglobulin G Stories

2014-05-27 23:11:01

Immunoglobulins or antibodies are proteins used by the immune system to neutralize pathogens including bacteria and viruses. The Life, Earth & Health Sciences Magazine EurekaMag.com has published 31,900 articles covering the interactions between a wide variety of immunoglobulins and pathogens particularly in humans. Mannheim, Germany (PRWEB) May 27, 2014 EurekaMag.com has published 31,900 articles on the importance of immunoglobulins for identifying and neutralizing pathogens such as...

2013-08-17 23:02:27

Market Reports Online now offers Global IVIG Market Report: 2013 Edition research that provides an analysis of the world wide Intravenous immunoglobulin market with a special focus on the IVIG market of the US. Dallas, Texas (PRWEB) August 17, 2013 The Intravenous immunoglobulin (IVIG) market is characterized by fast pace developments in the clinical technology and testing methodology. Despite challenges like stringent regulations and high cost of treatment, the global IVIG market is all...

2013-03-04 10:27:22

New research in the Journal of Clinical Investigation reveals that tumours in melanoma patients deliberately create conditions that knock out the body's 'premier' immune defence and instead attract a weaker immune response unable to kill off the tumour's cancerous cells. The study also highlights a potential antibody biomarker that could help predict prognosis and identify which patients are most likely to respond to specific treatments. The research, led by Dr Sophia Karagiannis and...

2011-06-22 08:00:00

NUTLEY, N.J. and BASEL, Switzerland, June 22, 2011 /PRNewswire/ -- The Roche manuscript: "Immunoglobulin Domain Crossover as a Generic Approach for the Production of Bispecific IgG Antibodies" has been published in the prestigious Proceedings of the National Academy of Sciences of the USA (PNAS). Corresponding authors are Wolfgang Schaefer, Research Leader Molecular Biology in Biologics Research at Penzberg, and Christian Klein, Head of Oncology Programs, Discovery Oncology at Roche...

2011-03-19 11:45:00

KING OF PRUSSIA, Pa., March 19, 2011 /PRNewswire/ -- CSL Behring today announced the development of an innovative pharmacokinetic (PK) model that allows the absorption, distribution, metabolism, and elimination of subcutaneous (SC) immunoglobulin G (IgG) following administration to be simulated with a high degree of accuracy and precision. The new PK model provides a novel means of simulating the mechanism by which SC IgG is transported after it is injected into the subcutaneous tissue....

2010-10-07 00:00:00

ISTANBUL, Oct. 7 /PRNewswire/ -- Vivaglobin® (subcutaneous immunoglobulin [IgG]) (SCIg) is an effective and safe initial therapy for treatment-naive patients with primary immunodeficiency (PI) and may offer an attractive alternative to intravenous IgG (IVIg) therapy in the newly diagnosed, according to data presented today at the XIVth Meeting of the European Society for Immunodeficiencies. The study found that IgG replacement therapy initiated with Vivaglobin in patients...

2010-10-07 00:00:00

ISTANBUL, Oct. 7 /PRNewswire/ -- Hizentra® (IgPro20) provides primary immunodeficiency (PI) patients with a safe and effective alternative to other immunoglobulin therapies when given in equivalent doses, according to Phase III pivotal trial data presented today at the XIVth Meeting of the European Society for Immunodeficiencies (ESID). Hizentra, the first and only 20 percent SCIg developed for subcutaneous (i.e., under the skin) administration, can be stored at room...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related